0001181431-12-042706.txt : 20120730
0001181431-12-042706.hdr.sgml : 20120730
20120730165805
ACCESSION NUMBER: 0001181431-12-042706
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120726
FILED AS OF DATE: 20120730
DATE AS OF CHANGE: 20120730
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ANDO DALE G
CENTRAL INDEX KEY: 0001202278
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30171
FILM NUMBER: 12994251
MAIL ADDRESS:
STREET 1: C/O CELL GENESYS INC
STREET 2: 500 FORBES BLVD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SANGAMO BIOSCIENCES INC
CENTRAL INDEX KEY: 0001001233
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 680359556
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 501 CANAL BLVD
STREET 2: POINT RICHMOND TECH CNTR.
CITY: RICHMOND
STATE: CA
ZIP: 94804
BUSINESS PHONE: 5109706000
MAIL ADDRESS:
STREET 1: 501 CANAL BLVD
STREET 2: POINT RICHMOND TECH CNTR.
CITY: RICHMOND
STATE: CA
ZIP: 94804
4
1
rrd351928.xml
FORM 4
X0306
4
2012-07-26
0
0001001233
SANGAMO BIOSCIENCES INC
SGMO
0001202278
ANDO DALE G
C/O SANGAMO BIOSCIENCES INC.
POINT RICHMOND TECH CNTR, 501 CANAL BLVD
RICHMOND
CA
94804
0
1
0
0
VP, Therapeutic Dev. & CMO
Common Stock
2012-07-26
4
S
0
1000
5.12
D
77534
D
Common Stock
2012-07-26
4
S
0
1500
5.09
D
76034
D
Common Stock
2012-07-26
4
S
0
1500
5.04
D
74534
D
Common Stock
2012-07-26
4
S
0
500
5.02
D
74034
D
Common Stock
2012-07-26
4
S
0
500
4.99
D
73534
D
Common Stock
2012-07-27
4
M
0
15000
3.61
A
88534
D
Common Stock
2012-07-27
4
S
0
15000
5.60
D
73534
D
Employee Stock Option (Right to Buy)
3.61
2012-07-27
4
M
0
15000
0
D
2014-08-01
Common Stock
15000
95800
D
The sales reported in this Form 4 were effected pursuant to the Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2012.
Includes 2,000 shares acquired by the Reporting Person on April 30, 2012 under the Issuer's Employee Stock Purchase Plan.
All shares underlying this option are vested and immediately exercisable.
/s/ Dale G. Ando
2012-07-26